SecBot SecBot
13FINSTITUTION · CIK 0001633313 · 2026-Q3 · Filed Nov 16, 2026

Avoro Capital Advisors

AVORO CAPITAL ADVISORS LLC
$9.7B
13F long value · 2026-Q3
Positions30
CategoryAsset manager
Quarters tracked10
●#472 of 556 by 13F long value
Size rank 2/10
5NEW2TRIM1EXIT
Snapshot
Avoro Capital Advisors's 13F portfolio at a glance: size, concentration and this quarter's activity.
13F long value
$9.7B
Positions
30 (1 unmapped)
Top 30 long weight
99.8%
Quarters tracked
10
Latest 13F filed
Nov 16, 2026
New positions
5
Exits / near-exits
1
13F long value by quarter
Reported long equity value each quarter: fund flows plus market moves. Option notional is not included.
$7.5B
2024-Q2
$6.9B
2024-Q3
$7.1B
2024-Q4
$6.4B
2025-Q1
$5.7B
2025-Q2
$7.7B
2025-Q3
$10.2B
2025-Q4
$10.2B
2026-Q1
$11.1B
2026-Q2
$9.7B
2026-Q3
Top holdings · 2026-Q3
The fund's largest reported positions. The long positions shown cover 99.8% of the long value.
TickerIssuerWeightValueSharesSince 2026-Q3
UTHR UNITED THERAPEUTICS CorpUNITED THERAPEUTICS Corp15.4%$1.5B2.8M+8.5%
ASND Ascendis Pharma A/SAscendis Pharma A/S11.9%$1.2B5.0M+19.3%
KRYS Krystal Biotech, Inc.Krystal Biotech, Inc.9.9%$960.7M2.9M-10.4%
ARGX ARGENX SEARGENX SE9.9%$958.9M1.0M-0.8%
MDGL MADRIGAL PHARMACEUTICALS, INC.MADRIGAL PHARMACEUTICALS, INC.9.5%$923.9M1.8M-15.9%
KYMR Kymera Therapeutics, Inc.Kymera Therapeutics, Inc.8.6%$835.6M7.5M+12.6%
ARWR ARROWHEAD PHARMACEUTICALS, INC.ARROWHEAD PHARMACEUTICALS, INC.7.4%$720.0M11.0M-32.5%
RVMD Revolution Medicines, Inc.Revolution Medicines, Inc.4.5%$440.3M2.1M-18.7%
CYTK CYTOKINETICS INCCYTOKINETICS INC3.3%$323.0M4.9M-19.3%
DFTX Definium Therapeutics, Inc.Definium Therapeutics, Inc.2.8%$268.3M7.0M-20.8%
GPCR Structure Therapeutics Inc.Structure Therapeutics Inc.2.1%$205.0M6.6M-40.6%
XENE Xenon Pharmaceuticals Inc.Xenon Pharmaceuticals Inc.2.1%$204.5M5.5M+5.6%
VERA Vera Therapeutics, Inc.Vera Therapeutics, Inc.1.9%$182.0M5.6M-16.5%
QURE uniQure N.V.uniQure N.V.1.7%$162.5M6.7M-9.4%
CELC Celcuity Inc.Celcuity Inc.1.2%$119.3M1.5M-23.8%
Quarterly changes · 2026-Q3
What Avoro Capital Advisors opened, added, trimmed and exited this quarter, largest dollar moves first.
ActionTickerIssuerPrev sharesCurr sharesChangeValue Δ
TRIMCELC TRIM Celcuity Inc. Celcuity Inc.3.4M1.5M-55.9%-$236.4M
EXITNo ticker EXIT DAMORA THERAPEUTICS INC DAMORA THERAPEUTICS INC3.8M0-100.0%-$98.4M
NEWDMRA NEW Damora Therapeutics, Inc. Damora Therapeutics, Inc.03.8MNew+$80.5M
NEWABVX NEW Abivax S.A. Abivax S.A.0488.0KNew+$48.3M
NEWSCTX NEW Scribe Therapeutics, Inc. Scribe Therapeutics, Inc.02.6MNew+$47.8M
NEWNo ticker NEW BIOHAVEN LTD BIOHAVEN LTD02.8MNew+$36.7M
NEWBRVE NEW Braveheart Bio, Inc. Braveheart Bio, Inc.01.3MNew+$25.4M
TRIMLXEO TRIM Lexeo Therapeutics, Inc. Lexeo Therapeutics, Inc.1.5M525.0K-64.7%-$5.2M
Conviction over time
Portfolio weight of the current top long holdings, quarter by quarter; rising weight = growing conviction.
UTHR 15.4%
ASND 11.9%
KRYS 9.9%
ARGX 9.9%
MDGL 9.5%
KYMR 8.6%
ARWR 7.4%
RVMD 4.5%
CYTK 3.3%
DFTX 2.8%